Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$150,000
+$27,500 QoQ
Shares Held
125,000
0.0% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026National Philanthropic Trust holds $18,931,409 across 7 Biotechnology names. FATE ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLNO |
Soleno Therapeutics Inc
|
200,000 | $6,696,000 | |
| 2 | INCY |
Incyte Corp
|
67,655 | $6,367,688 | |
| 3 | TECH |
BIO-TECHNE Corp
|
51,057 | $2,668,238 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
66,398 | $2,531,091 | |
| 5 | MRNA |
Moderna, Inc.
|
5,366 | $272,592 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
5,000 | $245,800 | |
| 7 | FATE |
Fate Therapeutics Inc
This page
|
125,000 | $150,000 |
All Filings in FATE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150,000 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $122,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $157,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $140,000 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $98,750 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $206,250 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $437,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $410,000 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2024-03-31 | $917,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $467,500 | 125,000 | Shares | Sole | 2026-06-12 | |
| No filing history on record for this holder in this stock. | ||||||